Beta Trace Protein (?CSF leak)
Specimen
Please collect minimum 0.5 ml into a white lid clear universal tube.
Test Usage
The leakage of cerebrospinal fluid (CSF) into nasal, oral or ear cavities or from a dermal sinus and its subsequent drainage from these cavities may be caused by trauma, intracranial surgical procedures, infection, hydrocephalus, congenital malformations and neoplasms. The most severe consequence of a CSF leak is microorganism contamination and the development of meningitis.
Epidemiology
- Prevalence – 70-80% are related to accidental trauma
- 2-4% of head injuries result in CSF leaks
- Age – middle age for spontaneous leaks, newborn for dermal sinuses
Etiology
- Trauma
- Non-traumatic:
- Surgery (usually spinal or neurosurgery)
- Postoperative defect
- Infection
- Tumor obstruction
- Congenital defects (at the base of the skull or at the end of the spinal cord)
- Hydrocephalus
- Spontaneous – no known defect or trauma
Pathophysiology
- Beta trace protein is found mainly in the CSF
- Interruption of the anterior cranial fossa floor allows leaks through the cribriform plate
- 80% of post-traumatic leaks occur in first 48 hours post-trauma
Clinical Presentation
- CSF leakage most commonly presents as otorrhoea or rhinorrhoea
- Patient may complain of salty or sweet taste; intermittent clear nasal discharge exacerbated by Valsalva maneuver
Diagnosis
- Indications for testing – presence of otorrhoea or rhinorrhoea; patient with recurrent episodes of meningitis
- Laboratory testing
- Chemical analysis (eg, Glucostix) of the fluid for glucose and protein is unreliable in determining the presence of CSF fluid
- The presence of Beta trace protein indicates CSF leakage (high specificity and sensitivity)
- False positives – chronic renal failure
- Imaging studies
- Radiographic studies, with or without intrathecal injection of dye or radioisotope, are not always successful in demonstrating small or delayed CSF leaks
- High resolution CT is initial study of choice
- MRI
- Cisternogram by CT or MRI
Turnaround time
Approx 1 month
Availability
Test referred to Neuroimmunology Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London.
Specimen Labelling Procedure